Cargando…
Chaperone‐mediated autophagy receptor modulates tumor growth and chemoresistance in non–small cell lung cancer
Chaperone‐mediated autophagy (CMA) is a lysosomal degradation pathway of selective soluble proteins. Lysosome‐associated membrane protein type 2a (LAMP2A) is the key receptor protein of CMA; downregulation of LAMP2A leads to CMA blockade. Although CMA activation has been involved in cancer growth, C...
Autores principales: | Ichikawa, Akihiro, Fujita, Yu, Hosaka, Yusuke, Kadota, Tsukasa, Ito, Akihiko, Yagishita, Shigehiro, Watanabe, Naoaki, Fujimoto, Shota, Kawamoto, Hironori, Saito, Nayuta, Yoshida, Masahiro, Hashimoto, Mitsuo, Minagawa, Shunsuke, Hara, Hiromichi, Motoi, Noriko, Yamamoto, Yusuke, Ochiya, Takahiro, Araya, Jun, Kuwano, Kazuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648026/ https://www.ncbi.nlm.nih.gov/pubmed/32860290 http://dx.doi.org/10.1111/cas.14629 |
Ejemplares similares
-
Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk
por: Kadota, Tsukasa, et al.
Publicado: (2021) -
Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia
por: Ito, Akihiko, et al.
Publicado: (2022) -
Role of chaperone-mediated autophagy in the pathophysiology including pulmonary disorders
por: Hosaka, Yusuke, et al.
Publicado: (2021) -
Early prediction of COVID‐19 severity using extracellular vesicle COPB2
por: Fujita, Yu, et al.
Publicado: (2021) -
Extracellular Vesicles in Chronic Obstructive Pulmonary Disease
por: Kadota, Tsukasa, et al.
Publicado: (2016)